NIH’s Collins on encouraging inter-disciplinary #science: you can’t herd cats but you can move their food #wef15
DAVOS, Switzerland, Jan 23 (Reuters) – India expects to hold
auctions for private firms to mine and sell coal in the near
future, the country’s coal and power minister Piyush Goyal said
but first wants to deal with mines that are directly linked to
plants that use the fuel.
To boost output and cut imports, Prime Minister Narendra
Modi passed an executive decree in December to open up India’s
nationalised coal industry. Bids have been invited from firms
that use coal for their own power, steel or cement plants.
DAVOS, Switzerland (Reuters) – Business leaders pushing for frictionless free trade have something new to worry about: the potential break-up of the Internet, which today forms the backbone of the global economy.
The issue is a hot topic at this year’s World Economic Forum in Davos, and the forum is seeking to provide a platform for debate over ways to maintain an open, cross-border Web in the face of pressures for national regulation.
DAVOS, Switzerland (Reuters) – The worst-ever Ebola epidemic is waning, but after ravaging three West African nations and spreading fear from Dallas to Madrid, it has hammered home the message that the world needs a better detective system for emerging diseases.
Risks posed by pandemic threats such as deadly strains of flu and drug-resistant superbugs have shot up the agenda of global security issues at this year’s World Economic Forum in Davos as politicians and scientists grapple with the lessons from an Ebola outbreak that has killed more than 8,600 people.
DAVOS, Switzerland, Jan 22 (Reuters) – The GAVI global
vaccines alliance is seeking to raise $7.5 billion at a funding
conference in Berlin next week, as its battle to prevent
infectious diseases in millions of children reaches an expected
The non-profit organisation, launched in Davos 15 years ago,
aims to immunise another 300 million children between 2016 and
2020, saving an estimated 5-6 million lives.
DAVOS, Switzerland, Jan 22 (Reuters) – Novartis
will review its Swiss cost base after the country’s central bank
scrapped a cap on the franc last week, sending the currency
soaring, the Swiss drugmaker’s chief executive said on Thursday.
“We’ll have to take a hard look at what’s in Switzerland and
what could move outside,” Joe Jimenez told Reuters on the
fringes of the World Economic Forum in Davos.